SINGAPORE, March 03, 2023 (GLOBE NEWSWIRE) — Novotech, the leading biotech CRO with a focus on Asia Pacific and extensive experience in vaccine trials, is hosting a webinar with expert panels covering the evolving landscape in vaccine development with Endpoints News . (To register Here)

Research data from Novotech shows that between 2017 and 2021 nearly 1,400 industry-sponsored vaccine-based clinical trials were conducted globally in a single country, with Asia-Pacific contributing to over 45% of the trials. Mainland China, India, Japan, Australia and South Korea were the frequently involved sites in the region.

During this period, the top 3 regions, including the US (369), EU7 (162), and APAC5 (541), collectively contributed over 1,000 vaccine trials, with Asia-Pacific contributing more than 50% of the global share of trials .

Download our latest data report here: Vaccines – Clinical Trial Landscape in Asia-Pacific

Novotech offers biotechs a unique and unparalleled suite of early- to late-stage CRO services across Europe and the US, with a focus on Asia Pacific, where the company has built a reputation for delivering quality accelerated clinical trials .

The Endpoints Webinar, Keeping pace with the evolving global landscape in vaccine development, will hear from a panel of life science experts on the latest advances and innovative modalities paving the way for global vaccine development, including:

• The impact of COVID-19 on drug development and the regulatory landscape, including mRNA vaccines.
• Key factors contributing to Asia Pacific being recognized as a hub for vaccine development and opportunities for biotechs.
• Key considerations for pre-clinical and clinical planning to accelerate vaccine development in support of a robust global strategy.
  

appointment time: March 9 11:00am – 12:00pm EST
to register Here

Panelists:

SUSHANT SAHASTRABUDDHE
ASSOCIATED DIRECTOR GENERAL, INTERNATIONAL VACCINE INSTITUTE (IVI)
dr Sushant Sahastrabuddhe, Deputy Director General of International Vaccine…